- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04291560
Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Although being sedentary can lead to excess risk for maternal and child mortality and morbidity, most pregnant women reduce their physical activity and only 8% meet the recommendations in the 3rd trimester.
In a prior randomized control trial, it was found that fewer women who stretched developed preeclampsia than did women who walked (3/60 "stretchers" vs. 10/64 "walkers", p=.05).
In this study, participants will either receive a stretching intervention
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- The University of North Carolina at Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant at less than 24 weeks gestation
- Singleton pregnancy
- BMI ≥ 30 kg/m^2 at their first prenatal care visit
- English or Spanish speaking
Exclusion Criteria:
- Women who expect or are scheduled to deliver prior to 37 weeks gestation
- Women who expect to move from the area during their participation in the study
- Women who are unable to exercise for 30 or more minutes 3 times per week
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prenatal Heart Smart Intervention
This group will have usual care completed and supportive calls from a facilitator to discuss adherence to the home exercise.
In addition, the group will complete a sequential static stretching exercise 5 days per week for 10 weeks.
The stretching exercise consists of 20 seconds of stretching, for 3 repetitions per muscle group.
|
Sequential static stretching of the large skeletal muscle group 5 days per week.
Each skeletal group is stretched for 20 seconds for 3 repetitions.
|
No Intervention: Usual Care (Control)
This group will have usual care completed and supportive calls from a facilitator to discuss adherence to the home exercise.
In addition, this group will complete moderate-intensity walking 5 days per week for 10 weeks in accordance to usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in systolic blood pressure from baseline (27 gestational weeks) to 32 gestational weeks
Time Frame: Baseline to 32 gestational weeks
|
Average systolic blood pressure measurement between two measurements, assessed at baseline (27 gestational weeks) and 32 gestational weeks.
Three total measurements will be taken, the first will be removed and the second two averaged.
|
Baseline to 32 gestational weeks
|
Change in systolic blood pressure from baseline (27 gestational weeks) to 37 gestational weeks
Time Frame: Baseline to 37 gestational weeks
|
Average systolic blood pressure measurement between two measurements, assessed at baseline (27 gestational weeks) and 37 gestational weeks.
Three total measurements will be taken, the first will be removed and the second two averaged.
|
Baseline to 37 gestational weeks
|
Change in diastolic blood pressure from baseline (27 gestational weeks) to 32 gestational weeks
Time Frame: Baseline to 32 gestational weeks
|
Average diastolic blood pressure measurement between two measurements, assessed at baseline (27 gestational weeks) and 32 gestational weeks.
Three total measurements will be taken, the first will be removed and the second two averaged.
|
Baseline to 32 gestational weeks
|
Change in diastolic blood pressure from baseline (27 gestational weeks) to 37 gestational weeks
Time Frame: Baseline to 37 gestational weeks
|
Average diastolic blood pressure measurement between two measurements, assessed at baseline (27 gestational weeks) and 37 gestational weeks.
Three total measurements will be taken, the first will be removed and the second two averaged.
|
Baseline to 37 gestational weeks
|
Change in sympatho-vagal balance projection period (PEP) for sympathetic activity from baseline (27 gestational weeks) to 32 gestational weeks
Time Frame: Baseline to 32 gestational weeks
|
he time in milliseconds from the ECG R point (left ventricular depolarization) and the B-point on the Dz/dt wave form (opening of the aortic valve), assessed at baseline (27 gestational weeks) and 32 gestational weeks.
|
Baseline to 32 gestational weeks
|
Change in sympatho-vagal balance projection period (PEP) for sympathetic from baseline (27 gestational weeks) to 37 gestational weeks
Time Frame: Baseline to 37 gestational weeks
|
The time in milliseconds from the ECG R point (left ventricular depolarization) and the B-point on the Dz/dt wave form (opening of the aortic valve), assessed at baseline (27 gestational weeks) and 37 gestational weeks.
|
Baseline to 37 gestational weeks
|
Change in high frequency of heart rate variability from baseline (27 gestational weeks) to 32 gestational weeks
Time Frame: Baseline to 32 gestational weeks
|
High frequency of heart rate variability (reported in absolute value, m^2/Hz) from an electrocardiogram, assessed at baseline (27 gestational weeks) and 32 gestational weeks.
|
Baseline to 32 gestational weeks
|
Change in high frequency of heart rate variability from baseline (27 gestational weeks) to 37 gestational weeks
Time Frame: Baseline to 37 gestational weeks
|
High frequency of heart rate variability (reported in absolute value, m^2/Hz) from an electrocardiogram, assessed at baseline (27 gestational weeks) and 37 gestational weeks.
|
Baseline to 37 gestational weeks
|
Change in arterial stiffness assessed by SphygmoCor XCEL from baseline (27 gestational weeks) to 32 gestational weeks
Time Frame: Baseline to 32 gestational weeks
|
Carotid-femoral pulse wave velocity is a measure of arterial stiffness reported in m/s.
Lower values reflect less arterial stiffness.
|
Baseline to 32 gestational weeks
|
Change in arterial stiffness assessed by SphygmoCor XCEL from baseline (27 gestational weeks) to 37 gestational weeks
Time Frame: Baseline to 37 gestational weeks
|
Carotid-femoral pulse wave velocity is a measure of arterial stiffness reported in m/s.
Lower values reflect less arterial stiffness.
|
Baseline to 37 gestational weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Onset of preeclampsia anytime between baseline (27 weeks gestation) and the end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of preeclampsia anytime between baseline (27 weeks gestation) and the end of pregnancy in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Onset of eclampsia anytime between baseline (27 weeks gestation) and the end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of eclampsia anytime between baseline (27 weeks gestation) and the end of pregnancy in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Onset of pregnancy induced hypertension anytime between baseline (27 weeks gestation) and the end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of pregnancy induced hypertension anytime between baseline (27 weeks gestation) and the end of pregnancy in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Onset of gestational diabetes anytime between baseline (27 weeks) and the end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of gestational diabetes anytime between baseline (27 weeks gestation) and the end of pregnancy in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Preterm delivery at end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of preterm delivery in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Elective or emergency cesarean section at end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of an elective or emergency cesarean section in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Composite score of Maternal Outcomes at the End of Pregnancy.
Time Frame: From baseline (27 weeks gestation) through delivery
|
The composite score of maternal outcomes (onset of preeclampsia, eclampsia pregnancy induced hypertension, gestational diabetes, preterm delivery, and elective or emergency cesarean section) is obtained at the end of pregnancy.
Scores range from 0-6, with higher scores indicating a less healthy pregnancy.
|
From baseline (27 weeks gestation) through delivery
|
Intrauterine death at end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of an intrauterine death in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Child being small for gestational age at the end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of the child being small for gestational age in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Child being large for gestational age at the end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of the child being large for gestational age in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Neonatal intensive care unit admission at the end of pregnancy
Time Frame: From baseline (27 weeks gestation) through delivery
|
Presence of a neonatal intensive care unit admission in the electronic medical record.
|
From baseline (27 weeks gestation) through delivery
|
Composite Score of Fetal/Neonatal Outcomes at the End of Pregnancy.
Time Frame: From baseline (27 weeks gestation) through delivery
|
The composite score of fetal/neonatal outcomes (intrauterine death, child being small, child being large, neonatal intensive care admission) is obtained at the end of pregnancy.
Scores range from 0-4, with higher scores indicating a less healthy fetus/neonate.
|
From baseline (27 weeks gestation) through delivery
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-3091
- 1R01NR017944-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
-
Guangzhou Sport UniversityUnknownChildhood Obesity | Adolescent ObesityChina
Clinical Trials on Stretching Exercise Intervention
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedMajor Depressive DisorderUnited States
-
VA Office of Research and DevelopmentCompletedExercise | AgingUnited States
-
University of Southern CaliforniaDana-Farber Cancer InstituteRecruitingHigh Intensity Interval Training | Overweight and Obesity | Cognition | Metabolic DiseaseUnited States
-
Tokat Gaziosmanpasa UniversityCompleted
-
Indiana UniversityNational Institute on Aging (NIA)CompletedDelirium | Alzheimer DiseaseUnited States
-
Dragan MijatovićCompletedStretchBosnia and Herzegovina
-
Eastern Mediterranean UniversityRecruiting
-
Istanbul University - Cerrahpasa (IUC)Active, not recruitingEffects of PNF and Static Stretching on Architecture and Viscoelastic Properties of Hemiplegic ElbowStroke | Spasticity, MuscleTurkey
-
Riphah International UniversityCompletedMusculoskeletal PainPakistan
-
Universidade Federal de Sao CarlosCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional...CompletedMusculoskeletal and Connective Tissue DisordersBrazil